yudejavu (DejanV.): RT @crusadernz: BioPharmCatalyst updates: http://t.co/lTH42dUS $ISIS PDUFA date set. $LGND/$GSK/$EXEL NDA filings + $CLSN $ALNY $INSM $ACRX news
13 hours and 47 minutes ago
stocklist79 (David): $ISIS - ISIS Pharmaceuticals, Stock Analysis - first hour trading - http://t.co/dXCDaxba
13 hours and 51 minutes ago
LTbioinvestor (max): RT @crusadernz: BioPharmCatalyst updates: http://t.co/lTH42dUS $ISIS PDUFA date set. $LGND/$GSK/$EXEL NDA filings + $CLSN $ALNY $INSM $ACRX news
18 hours and 46 minutes ago
crusadernz (BioPharmCatalyst): BioPharmCatalyst updates: http://t.co/lTH42dUS $ISIS PDUFA date set. $LGND/$GSK/$EXEL NDA filings + $CLSN $ALNY $INSM $ACRX news
19 hours and 18 minutes ago
portefeuillefun (V.S. Schulz): The $ISIS share price is close to "making a 2y high". 7000 ISIS shares in the fund with break-even of around 8.00 USD.
19 hours and 25 minutes ago
TheDailyTrade (Market Trader Daily): $ISIS 10.0 new high
20 hours and 17 minutes ago
beststocks98 (Nelson): $ISIS Stock under $10 - Stock Analysis practice trading - http://t.co/IOyNdMhn
21 hours and 36 minutes ago
noodls_sHealth (Healthcare Stocks): $ISIS Isis Pharmaceuticals to Present at the Goldman Sachs 33rd... http://t.co/GOvgDMyo
21 hours and 42 minutes ago
yudejavu (DejanV.): RT @BioDueDiligence: KYNAMRO (mipomersen) NDA accepted by FDA triggering $25m milestone- $ISIS $SNY have 1/29/13 PDUFA date: http://t.co/zRXZIbnx
1 day and 16 hours ago
anthonyh845 (anthony h): $ISIS - ISIS Pharmaceuticals, Stock Analysis - day trading formulas - http://t.co/LXarmZBy
1 day and 17 hours ago
MogulAzam (MogulAzam): RT @BioWorld: FDA accepts Genzyme NDA for antisense oligonucleotide Kynamro in homozygous familial hypercholesterolemia; triggers $25M milestone to $ISIS
1 day and 18 hours ago
Mayur7775 (Mayur Kherdikar): RT @BioWorld: FDA accepts Genzyme NDA for antisense oligonucleotide Kynamro in homozygous familial hypercholesterolemia; triggers $25M milestone to $ISIS
1 day and 18 hours ago
mariempowers (Marie Powers): RT @BioWorld: FDA accepts Genzyme NDA for antisense oligonucleotide Kynamro in homozygous familial hypercholesterolemia; triggers $25M milestone to $ISIS
1 day and 18 hours ago
BioWorld (BioWorld Today): FDA accepts Genzyme NDA for antisense oligonucleotide Kynamro in homozygous familial hypercholesterolemia; triggers $25M milestone to $ISIS
1 day and 18 hours ago
scientre (Laura Strong): RNAi MT @bioduediligence: KYNAMRO (mipomersen) NDA accepted by FDA trigger $25m milestone $ISIS $SNY 1/29/13 PDUFA date http://t.co/aIlWpYLD
1 day and 19 hours ago
